London conferenne Nov 4: Adverse psychiatric effects of medicines

[Guest guest]

SSRI-Research@

Wed, 20 Oct 2004 01:26:48 -0400

Subject:[sSRI-Research] Adverse psychiatric effects of medicines

London conferenne Nov 4

 

 

 

[-- Please forward to anyone, or any organisation that you think may

be interested in this important meeting.]

 

 

London conference

Thursday November 4th 2004

 

Adverse Psychiatric Effects of Medicines and Anaesthetics ...preventing

avoidable harm

 

Friends House 173 Euston Road, (opposite Euston Station) 9 am – 5 pm

 

The sytem of collecting data of adverse drug reactions is not working

to protect the public. Pre licence clinical drug trials with results

unfavourable to the product, are often undisclosed. Many people are

suffering due to adverse effects which are not recognised as such and

treated as new disease.

 

Education is failing the professionals, regulation is failing the

public.

 

 

You are invited to join us and to contribute to finding solutions.

Leading academics, clinicians, professors and a coroner will be

discussing

the issues around the recognition and prevention of adverse drug

reactions and the regulation and safety of medicines.

 

 

 

Those concerned about important public health issues including suicide,

self harming, dementia, violence and the increasing numbers of people

harmed by their medicines, should not miss this conference.

 

 

 

Drugs currently being prescribed and some being marketed direct to the

public are not proven to be safe for everyone.

 

 

 

The conference will provide a forum for sharing knowledge and

facilitate debate about ADR prevention, reporting, analysis and risk

management.

A rare opportunity for open communication between the industry,

research analysts, health care professionals, pharmacists, regulators,

policy

makers & the public.

 

 

Ø Up to 30% of adverse drug reactions (ADRs) are neuropsychiatric

 

 

 

Ø Depression, self-harm, aggression, psychosis, suicide, dementia

may be ADRs & prevention is possible for these and other long tem

iatrogenic (medication induced) disease

 

 

 

Ø ADRs after anaesthetics are not researched or analysed

 

 

 

Ø Adverse events & ADRs in NHS hospitals cost estimated £2 billion

a year & contribute to thousands of deaths

 

 

 

Speakers

Dr Andrew Herxheimer Clinical Pharmacologist, Founder of Drug and

Therapeutics Bulletin

 

Charles Medawar Founder/director Social Audit; Specialist

in Medicines Policy & Drug Safety Issues

 

Prof. Saad Shakir Director of the Drug Safety Research Unit

(DSRU)

 

Keith Altman USA Adverse Drug Reactions Statistics

Analyst

 

Leonard Gorodkin H.M. Coroner, City of Manchester

 

Dr Dorothy Rowe Clinical Psychologist, author

 

Dr John Halliday Pharmacology and Therapeutics Sub Dean

Basic Med. Science King's Col. London

 

Steve Mott Datapharm director, ABPI drug data

 

Dr Anita Holdcroft Reader in Anaesthesia & Hon. Consultant

Anaesthetist Chelsea & Westminster Hospital Faculty of Medicine

Imperial

College, London

 

Panel members and chairs

 

Angela Clow Prof.

Psychophysiology, Univ. of Westminster & Stress Test co-presenter BBC 1

 

Martin Seager psychologist, Dr Diane Samways, Dr Walter Loebl

 

 

 

Venue Friends House, 173 Euston Road, London NW1

 

(Opposite Euston

Station)

 

Date Thursday 4th November 2004

 

Time 9.30am to 5.00pm (registration 9am)

 

Delegate fees From £35 concessions £115 if funded

 

Registration Application form to download on website

www.april.org.uk

 

Tel: EYAS Ltd +44 (0)1243 775

561 or email april

 

 

 

NO ONE WILL BE TURNED AWAY. FOR SUBSIDISED RATES &

 

PRESS ENQUIRIES CONTACT millie or telephone: 01992 813111

 

Organiser APRIL a charity registered in England no 1072305,

 

company limited by guarantee no

 

Suite 4, Auction Square, Market Place, Abridge, Essex RM4 1UA www.